In this article an infectious diseases pharmacist compares Paxlovid versus molnupiravir - the first oral COVID-19 antivirals with FDA Emergency Use Authorization. Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 24 December 2021 The FDA has released emergency use authorizations for Pfizer's COVID-19 pill Paxlovid (generic … [Read more...]

In this article an infectious diseases pharmacist identifies five things for pharmacists to know about the Omicron variant of SARS-CoV-2.  Authored by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 20 December 2021 As the SARS-CoV-2 pandemic moves into 2022 the concept of "many good questions, few good answers" remains a theme. Until … [Read more...]

In this article Dr. Jeff Boden of the global branding consultancy Kaleio, Inc. (who developed the name molnupiravir) provides some history on molnupiravir - the new COVID antiviral named after Thor's Hammer.  Authored by: Jeff Boden, Ph.D. Article posted: 1 October 2021 On October 1st, Merck and Ridgeback Biotherapeutics announced that molnupiravir … [Read more...]

Wondering how Comirnaty was named? Well you have come to the right place! In this article Dr. Jeff Boden of the global branding consultancy Kaleio, Inc. provides the story behind Pfizer's oddly named mRNA vaccine. Authored by: Jeff Boden, Ph.D. Article Posted: 24 August 2021 On August 23rd, FDA approved the BLA for the Pfizer-BioNTech COVID-19 … [Read more...]